3D·

Krystal Biotech, Inc. increases profit in the 4th quarter

$KRYS (+3.28%)

Krystal Biotech, Inc. ( KRYS ) announced fourth quarter earnings that were up from the same period last year


The company's net income totaled $45.48 million, or $1.52 per share. In the previous year, it amounted to 8.69 million US dollars or 0.30 US dollars per share.


The company's turnover increased by 116.3 % from 42.14 million US dollars in the previous year to 91.14 million US dollars in this period.


The results of Krystal Biotech, Inc. at a glance (GAAP):


-Profit: $45.48 million compared to $8.69 million last year.

-EPS: $1.52 vs. $0.30 last year.

-Revenue: $91.14 million compared to $42.14 million last year.


https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-fourth-quarter-and-full-year-2024


https://www.rttnews.com/3514054/krystal-biotech-inc-bottom-line-advances-in-q4.aspx

previw image
6
Join the conversation